
Pacific Biosciences of California
Price & Volume
Stats
See more52W Range | $1.07-$3.44 |
Market Cap | $574.5M |
Shares Short | 53M |
Financials
See moreRevenue (12 Mos) | $161.3M |
Revenue Growth (YoY) | 5.5% |
Gross Profit (12 Mos) | $44.6M |
Diluted EPS | -$0.42 |
News
See moreYahoo Finance • 13 days ago
PacBio narrows 2026 revenue guidance to $155M-$160M while targeting cash flow breakeven in 2028
Yahoo Finance • 14 days ago
Pacific Biosciences of California Non-GAAP EPS of -$0.11 beats by $0.02, revenue of $40.6M beats by $1.14M
Yahoo Finance • 30 days ago
PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI
Yahoo Finance • 2 months ago
Catalyst Watch: Microsoft event, FOMC talk, and the finish line for Paramount-Warner Bros.
About
CEO | Mr. Mark Van Oene Ph.D. |
CFO | Mr. Mark Van Oene Ph.D. |
Address | 1305 O?Brien Drive, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 485 |